Showing results (81-90 of 208) with videos related to
Sort By:
Pageof 21
European Journal of Biochemistry|February 1, 1981
Synthesis and biological properties of enzyme-resistant analogues of substance PB E Sandberg, C M Lee, M R Hanley, et al.European Journal of Pharmacology|November 4, 1986
Multiple tachykinin binding sites in peripheral tissues and in brainC M Lee, N J Campbell, B J Williams, et al.The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|June 21, 2001
Remotivation therapy and Huntington's diseaseF R Sullivan, E D Bird, M Alpay, et al.Psychiatry Research|December 1, 1992
Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjectsA F Oke, C Putz, R N Adams, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brainR L Neve, E A Finch, E D Bird, et al.Neurology|May 1, 1984
Somatostatin is increased in the nucleus accumbens in Huntington's diseaseM F Beal, E D Bird, P J Langlais, et al.Neuroscience|January 1, 1990
Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortexB A Vogt, M D Plager, P B Crino, et al.Neurology|October 1, 1989
Phenotypic variation in 2 Huntington's disease families with linkage to chromosome 4D S Sax, E D Bird, J F Gusella, et al.Annals of Neurology|July 1, 1982
Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brainF X Walsh, T J Stevens, P J Langlais, et al.Biological Psychiatry|February 1, 1981
Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's diseaseE D London, H I Yamamura, E D Bird, et al.Pageof 21